Skip to content

Opening book details…

Can I read Collagen-based scaffolds: An auspicious tool to support repair, recovery, and regeneration post spinal cord injury on EtoBox?

Collagen-based scaffolds: An auspicious tool to support repair, recovery, and regeneration post spinal cord injury by Amina T. Mneimneh; Mohammed M. Mehanna is a Pharmacology, Toxicology and Pharmaceutics article available to read on EtoBox.

What is Collagen-based scaffolds: An auspicious tool to support repair, recovery, and regeneration post spinal cord injury about?

Spinal cord injury (SCI) is a perplexing traumatic disease that habitually gives ride to permanent disability, motor, and sensory impairment. Despite the existence of several therapeutic approaches for the injured motor or sensory neurons, they can't promote axonal regeneration. Whether prepared by conventional or rapid prototyping techniques, scaffolds can be applied to refurbish the continuity of the injured site, by creating a suitable environment for tissue repair, axonal regeneration, and vascularization. Collagen is a multi-sourced protein, found in animals skin, tendons, cartilage, bones, and human placenta, in addition to marine biomass. Collagen is highly abundant in the extracellular matrix and is known for its biocompatibility, biodegradability, porous structure, good permeability, low immunogenicity and thus is extensively applied in the pharmaceutical, cosmetic, and food industries as well as the tissue engineering field. Collagen in scaffolds is usually functionalized with different ligands and factors such as, stem cells, embryonic or human cells to augment its binding specificity and activity. The review summarizes the significance of collagen-based scaffolds and th

Who reads Collagen-based scaffolds: An auspicious tool to support repair, recovery, and regeneration post spinal cord injury?

It is typically read by researchers, students, and practitioners in Pharmacology, Toxicology and Pharmaceutics.

Author
Amina T. Mneimneh; Mohammed M. Mehanna
Publisher
Elsevier BV
Published
2021
Language
EN
Field
Pharmacology, Toxicology and Pharmaceutics (Life Sciences)